Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion type Assertion NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_head.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion description "[Consistent with the PBMC data, IL-2 and IL-4 RNA were also more frequently detectable in skin biopsies with GVHD (n = 10): 70% of samples expressed IL-2 vs. 25% of normal controls (n = 8; P < 0.05); 60% had detectable IL-4 RNA vs. 0% of controls (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_provenance.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion evidence source_evidence_literature NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_provenance.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion SIO_000772 7652763 NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_provenance.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion wasDerivedFrom befree-2016 NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_provenance.
- NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_assertion wasGeneratedBy ECO_0000203 NP1316586.RAC-KzaB2ZvV4BvyyIIRsuUvo1BAr126ihW3B4G7O69w8130_provenance.